Clinical Trials in Detroit

Showing 3441-3460 of 19,719 trials

Syncing Screening and Services for Suicide Prevention Across Health and Justice Systems

NCT06506344

This study aims to harmonize jail release record data with electronic health record data in order to connect patients to an evidence-based suicide prevention and clinical care pathway upon jail release.

Suicide Prevention

Henry Ford Health System5,250 participantsStarted Jun 2024

Detroit, Michigan, United States • Bloomington, Minnesota, United States

RECRUITINGPhase 1< 1 mile

FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors

NCT06241456

This is a phase 1 study designed to evaluate the safety, tolerability, and antitumor activity of FT825 (also known as ONO-8250) with or without monoclonal antibody therapy following chemotherapy in participants with advanced human epidermal growth factor receptor 2 (HER2)-positive or other advanced solid tumors. The study will consist of a dose-escalation stage, followed by an expansion stage to further evaluate the safety and activity of FT825 in indication-specific cohorts.

Advanced Solid Tumor

Fate Therapeutics351 participantsStarted Jan 2024

Gilbert, Arizona, United States • La Jolla, California, United States • New Haven, Connecticut, United States +11 more locations

Syncing Screening and Services for Suicide Prevention Across Health and Justice Systems

FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors

Find Trials by Condition in Detroit

Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer

Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine

A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors

Lead EvaluAtion for Defibrillation and Reliability (LEADR) / Lead Evaluation for Defibrillation and Reliability in Left Bundle Branch Area Pacing (LEADR LBBAP)

A Study of ELAPRASE in Treatment-naïve Participants With Hunter Syndrome (Mucopolysaccharidosis [MPS] II)

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM)

MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLC

Re-Ablation Using a Tailored Approach Targeting EGM-Dispersion

A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer

Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma

A Dose-finding Study to Evaluate the Effect of a Contraceptive Vaginal Ring, Releasing Nestorone® and Estradiol, on Cycle Control, Ovulation Inhibition, and Pharmacokinetics in Normal Cycling Women

Chyme Reinfusion for Type 2 Intestinal Failure

A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)

Acalabrutinib (ACP-196) in Combination With ACP-319, for Treatment of B-Cell Malignancies

CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor

Tube Size Randomized Trial During Emergency Tracheal Intubation

Ceftibuten/VNRX-7145 in Participants With Varying Degrees of Renal Function

Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations